Turing Pharmaceutical CEO and former hedge fund manager Martin Shkreli has been indicted by federal officers in a multimillion dollar scheme related to his former company, Retrophin.
Martin Shkreli Faces Fraud And Conspiracy Charges
Turing Pharmaceutical CEO and former hedge fund manager Martin Shkreli has been indicted by federal officers in a multimillion dollar scheme related to his former company, Retrophin.
Dec 18, 2015
Latest in Operations
Nvidia CEO Huang Says He's Disappointed by China Chip Curbs
September 17, 2025
Why Manufacturers Should Look Closer at Federal Innovation
September 16, 2025
Regional Manufacturing: The Future of a Resilient Industry
September 16, 2025